Expanding range of dry eye diagnostics valuable to ophthalmologists
Click Here to Manage Email Alerts
NEW ORLEANS — Cynthia Matossian, MD, FACS, discussed the value of dry eye diagnostics at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting.
“Dry eye disease is ubiquitous, and we are so fortunate to have ever-growing options for treatments to help our patients with dry eye disease,” she said. “However, in my opinion, there is a disconnect between the availability of dry eye diagnostics.”
Matossian said that some of the benefits of dry eye disease (DED) diagnostics include easy accessibility and ability to monitor treatment effectiveness and treatment compliance. She also discussed new diagnostic tools for DED, including a bidirectionally formatted digital questionnaire, which can be integrated with the patient’s EMR, saves time and money, and helps measure patient satisfaction.
Matossian discussed a hand-held tear osmolarity test with a swappable tip that can be used for MMP-9 or tear osmolarity and an AI-based algorithm that helps guide treatment options by inputting diagnostic results.
For patients with dry eye, telehealth is a good opportunity for follow-up, she said. One company, Myze, uses text messages and other digital reminders to engage patients.
“Dry eye testing is really valuable,” Matossian said. “We don’t have too many options right now, but hopefully by each of you using these more, there will be opportunities for newer tests to come to the market.”
Collapse
Matossian C. New diagnostics for the ocular surface. Presented at: American Academy of Ophthalmology meeting, Nov. 12-15, 2021; New Orleans.
Read more about
Click Here to Manage Email Alerts